1. Superior Survival of Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Compared with Chemotherapy Alone Used as Post-Remission Therapy in Adults with Standard-Risk Acute Lymphoblastic Leukemia in First Complete Remission 
Chen-Hua Yan, Qian Jiang, Jing Wang, Lan-Ping Xu, Dai-Hong Liu, Hao Jiang, Huan Chen, Xiao-hui Zhang, Kai-yan Liu, Xiao-Jun Huang 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 9, Pages (September 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Diagrams of intervention strategies (A) and patient subgroups (B).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Relapse, treatment-related mortality, OS, and DFS in all patients (N = 138). (A) Cumulative incidence of relapse. (B) Cumulative incidence of treatment-related mortality. (C) OS. (D) DFS. Of the 138 patients enrolled in this study, 59 patients received chemotherapy alone (group A) and 79 patients received haploidentical HSCT (group B).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Relapse, treatment-related mortality, OS, and DFS of patients based on risk stratification (N = 120). (A) Cumulative incidence of relapse. (B) Cumulative incidence of treatment-related mortality. (C) OS. (D) DFS. According to the risk factors for relapse, 138 patients were stratified into low-risk and high-risk groups. Fifty-nine patients without risk factors for relapse were stratified into the low-risk group, 61 patients with risk factors were stratified into the high-risk group, and 18 patients were not evaluated in this analysis because of no MRD monitoring results during follow-up.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Relapse, treatment-related mortality, OS, and DFS of patients based on risk stratification and intervention strategies (N = 120). (A) Cumulative incidence of relapse. (B) Cumulative incidence of treatment-related mortality. (C) OS. (D) DFS. One hundred twenty patients were evaluated in this analysis, but 18 patients were not evaluated because of no MRD monitoring results during follow-up. These 120 patients were further divided into 4 groups: patients without risk factors and receiving chemotherapy (chemo-low, n = 24), patients with risk factors and receiving chemotherapy (chemo-high, n = 20), patients without risk factors and receiving HSCT (HSCT-low, n = 35), and patients with risk factors and receiving HSCT (HSCT-high, n = 41). P1 represents the comparison among 4 groups, and P2 represents the comparison among chemo-low, HSCT-low, and HSCT-high.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions